McKee Medical Center

Claim this profile
,
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
310 reported clinical trials
9 medical researchers

Summary

McKee Medical Center is a medical facility located in undefined, undefined. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. McKee Medical Center is involved with conducting 310 clinical trials across 421 conditions. There are 9 research doctors associated with this hospital, such as Nicholas DiBella, Eric Anderson, Supriya Jain, and Robin A. Lacour, MD.

Area of expertise

1Cancer
Global Leader
McKee Medical Center has run 97 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
McKee Medical Center has run 62 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at McKee Medical Center

Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Prostate Cancer
Bladder Cancer
Squamous Cell Carcinoma
Melanoma
Colorectal Cancer
Cutaneous Melanoma
Image of trial facility.

Support Program

for Breast Cancer

This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Sacituzumab Govitecan

for Brain Metastases from Breast Cancer

This phase II trial studies the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain (brain metastases). Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted therapy because it attaches to specific molecules on the surface of cancer cells, known as Trop-2 receptors, and delivers govitecan to kill them. Giving sacituzumab govitecan may shrink the cancer in the brain and/or extend the time until the cancer gets worse.
Recruiting1 award Phase 212 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at McKee Medical Center?
McKee Medical Center is a medical facility located in undefined, undefined. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. McKee Medical Center is involved with conducting 310 clinical trials across 421 conditions. There are 9 research doctors associated with this hospital, such as Nicholas DiBella, Eric Anderson, Supriya Jain, and Robin A. Lacour, MD.